CUAMC
ATXS

China Universal Asset Management Company’s Astria Therapeutics ATXS Stock Holding History

China Universal Asset Management Company’s Portfolio ATXS Stock Details ATXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-9,892
Closed -$72K – 504
2025
Q3 		$72K Sell
9,892
-1,443
-13% -$9.77K 0.01% 409
2025
Q2 		$60.8K Buy
11,335
+15
+0.1% +$73 0.01% 408
2025
Q1 		$60.4K Sell
11,320
-646
-5% -$4.52K 0.01% 401
2024
Q4 		$107K Buy
+11,966
New +$127K 0.01% 385

Other funds holding ATXS

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

China Universal Asset Management Company's ATXS Position: Q4 2025 in Review

China Universal Asset Management Company sold out of Astria Therapeutics (ATXS) in Q4 2025, closing a stake of 9,892 shares — an estimated $72K sold.

China Universal Asset Management Company first reported a position in ATXS in Q4 2024 and held it in 4 quarters. The position peaked at $107K in Q4 2024. 141 funds tracked by Wall St. Rank hold ATXS as of Q4 2025.

  • China Universal Asset Management Company reported no remaining Astria Therapeutics position as of Q4 2025 after selling out during the quarter.
  • China Universal Asset Management Company sold 9,892 Astria Therapeutics shares in Q4 2025, an estimated $72K.
  • China Universal Asset Management Company first reported a position in Astria Therapeutics in Q4 2024 and held it in 4 quarters.
  • China Universal Asset Management Company's Astria Therapeutics position peaked at $107K in Q4 2024.
  • 141 funds tracked by Wall St. Rank held Astria Therapeutics as of Q4 2025.

Based on China Universal Asset Management Company's 13F filing for Q4 2025, filed 29 Jan 2026.